Enveric Biosciences, Inc. Quarterly Goodwill in USD from Q3 2015 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Enveric Biosciences, Inc. quarterly Goodwill history and growth rate from Q3 2015 to Q3 2023.
  • Enveric Biosciences, Inc. Goodwill for the quarter ending September 30, 2023 was $253K, a 82.8% decline year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $253K -$1.22M -82.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $295K -$1.27M -81.1% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $337K -$1.27M -79% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $380K -$1.21M -76.1% Dec 31, 2022 10-Q 2023-11-13
Q3 2022 $1.47M -$7.59M -83.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.56M Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $1.61M Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $1.59M Dec 31, 2021 10-K 2024-03-26
Q3 2021 $9.06M -$4.67M -34% Sep 30, 2021 10-Q 2021-11-15
Q3 2020 $13.7M $0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $13.7M $0 0% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $13.7M $0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $13.7M $0 0% Dec 31, 2019 10-Q 2020-11-16
Q3 2019 $13.7M -$8.17M -37.3% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $13.7M -$8.17M -37.3% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $13.7M -$8.17M -37.3% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $13.7M -$8.17M -37.3% Dec 31, 2018 10-K/A 2020-08-12
Q3 2018 $21.9M +$11.8K +0.05% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $21.9M +$11.8K +0.05% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $21.9M +$18.8K +0.09% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $21.9M +$4.81M +28.1% Dec 31, 2017 10-K 2019-03-26
Q3 2017 $21.9M +$4.51M +25.9% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $21.9M +$18.1M +473% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $21.9M +$18.2M +496% Mar 31, 2017 10-Q/A 2017-05-15
Q4 2016 $17.1M +$13.6M +392% Dec 31, 2016 10-K 2018-04-02
Q3 2016 $17.4M +$13.9M +401% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $3.82M Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $3.67M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 $3.47M Dec 31, 2015 10-K/A 2017-04-04
Q3 2015 $3.47M Sep 30, 2015 10-Q 2015-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.